ViroMed's clinical development of VM202-ALS is well underway, its update has
been picked up on ALS News Today.
“First Trial of Potential
ALS Gene Therapy VM202 Shows Treatment’s Safety”
Link to the article: Potential
ALS Gene Therapy VM202 Seen As Safe in First Clinical Trial
News Today is a daily digital news journal
that seeks to give ALS patients and their support systems access to the
latest science and research news pertaining to the disease. While there is a
great deal of research and development underway for treating ALS, very little
news is reported in the health media. ALS News Today seeks to fulfill the
unmet need in health reporting by levering our talented group of researchers
and journalists to source the latest ALS-related news and present it in a
format that patients can easily understand.